New paradigms in cell death in human diabetic nephropathy

Kidney International

Volumn 78, Issue 8, 2010, Pages 737-744

  Sanchez Niño, Maria Dolores ^a   Benito Martin, Alberto ^a   Ortiz, Alberto ^a,b  

^a UAM)   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

apoptosis; BASP1; CD74; diabetic nephropathy; MIF; TRAIL

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALLOGRAFT INFLAMMATORY FACTOR 1; BCL2 RELATED PROTEIN A1; BH3 PROTEIN; BRAIN ACID SOLUBLE PROTEIN 1; CASPASE; CD36 ANTIGEN; CD74 ANTIGEN; CYTOCHROME C; CYTOKINE; FAS ANTIGEN; GLUCOSE; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEAT SHOCK PROTEIN 70; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL XL; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DEATH; CELL LOSS; CELL STRESS; CELL SURVIVAL; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HYPOXIA; KIDNEY TUBULE CELL; MICROARRAY ANALYSIS; MICROENVIRONMENT; MITOCHONDRION; MOLECULAR INTERACTION; OXIDATIVE STRESS; PODOCYTE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 77957595369     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.270     Document Type: Short Survey

References (50)

1. Navarro JF, Mora-Fernandez C. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine Growth Factor Rev 2006; 17: 441-450.
2. Ortiz A, Ziyadeh FN, Neilson EG. Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Investig Med 1997; 45: 50-56.
3. Kelly DJ, Stein-Oakley A, Zhang Y et al. Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2)27 rats: attenuation with renin-angiotensin blockade. Nephrology (Carlton) 2004; 9: 7-13.
4. Sanchez-Nino MD, Sanz AB, Lorz C et al. BASP1 promotes apoptosis in diabetic nephropathy. J Am Soc Nephrol 2010; 21: 610-621.
5. Gilbert RE, Marsden PA. Activated protein C and diabetic nephropathy. N Engl J Med 2008; 358: 1628-1630.
6. Verzola D, Gandolfo MT, Ferrario F et al. Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int 2007; 72: 1262-1272.
7. Hohenstein B, Hausknecht B, Boehmer K et al. Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int 2006; 69: 1654-1661.
8. Susztak K, Ciccone E, McCue P et al. Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy. PLoS Med 2005; 2: e45.
9. Lorz C, Benito-Martin A, Boucherot A et al. The death ligand TRAIL in diabetic nephropathy. J Am Soc Nephrol 2008; 19: 904-914.
10. Sanchez-Nino MD, Sanz AB, Ihalmo P et al. The MIF receptor CD74 in diabetic podocyte injury. J Am Soc Nephrol 2009; 20: 353-362.
11. Schmid H, Boucherot A, Yasuda Y et al. Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 2006; 55: 2993-3003.
12. Lindenmeyer MT, Rastaldi MP, Ikehata M et al. Proteinuria and hyperglycemia induce endoplasmic reticulum stress. J Am Soc Nephrol 2008; 19: 2225-2236.
13. Sanz AB, Santamaria B, Ruiz-Ortega M et al. Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol 2008; 19: 1634-1642.
14. Wagener FA, Dekker D, Berden JH et al. The role of reactive oxygen species in apoptosis of the diabetic kidney. Apoptosis 2009; 14: 1451-1458.
15. van der Kallen CJ, van Greevenbroek MM, Stehouwer CD et al. Endoplasmic reticulum stress-induced apoptosis in the development of diabetes: is there a role for adipose tissue and liver? Apoptosis 2009; 14: 1424-1434.
16. Lorz C, Justo P, Sanz A et al. Paracetamol-induced renal tubular injury: a role for ER stress. J Am Soc Nephrol 2004; 15: 380-389.
17. Roy S, Sharom JR, Houde C et al. Confinement of caspase-12 proteolytic activity to autoprocessing. Proc Natl Acad Sci USA 2008; 105: 4133-4138.
18. Moley KH, Chi MM, Knudson CM et al. Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med 1998; 4: 1421-1424.
19. Justo P, Sanz AB, Egido J et al. 3,4-Dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells. Diabetes 2005; 54: 2424-2429.
20. Lee SH, Yoo TH, Nam BY et al. Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions. Am J Physiol Renal Physiol 2009; 297: F1381-F1390.
21. Singh DK, Winocour P, Farrington K. Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy. Nat Clin Pract Nephrol 2008; 4: 216-226.
22. Liu F, Brezniceanu ML, Wei CC et al. Overexpression of angiotensinogen increases tubular apoptosis in diabetes. J Am Soc Nephrol 2008; 19: 269-280.
23. Ortiz A, Lorz C, Egido J. The Fas ligand/Fas system in renal injury. Nephrol Dial Transplant 1999; 14: 1831-1834.
24. Lorz C, Benito A, Ucero AC et al. Trail and kidney disease. Front Biosci 2009; 14: 3740-3749.
25. Falschlehner C, Ganten TM, Koschny R et al. TRAIL and other TRAIL receptor agonists as novel cancer therapeutics. Adv Exp Med Biol 2009; 647: 195-206.
26. Zheng SJ, Wang P, Tsabary G et al. Critical roles of TRAIL in hepatic cell death and hepatic inflammation. J Clin Invest 2004; 113: 58-64.
27. Zou Y, Zhang X, Mao Y et al. Acute toxicity of a single dose DATR, recombinant soluble human TRAIL mutant, in rodents and crab-eating macaques. Hum Exp Toxicol 2010.
28. Mi QS, Ly D, Lamhamedi-Cherradi SE et al. Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice. Diabetes 2003; 52: 1967-1975.
29. Zauli G, Melloni E, Capitani S et al. Role of full-length osteoprotegerin in tumor cell biology. Cell Mol Life Sci 2009; 66: 841-851.
30. Pritzker LB, Scatena M, Giachelli CM. The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival. Mol Biol Cell 2004; 15: 2834-2841.
31. Rasmussen LM, Tarnow L, Hansen TK et al. Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients. Eur J Endocrinol 2006; 154: 75-81.
32. Sasaki S, Nishihira J, Ishibashi T et al. Transgene of MIF induces podocyte injury and progressive mesangial sclerosis in the mouse kidney. Kidney Int 2004; 65: 469-481.
33. Schwartz V, Lue H, Kraemer S et al. A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett 2009; 583: 2749-2757.
34. Carpenter B, Hill KJ, Charalambous M et al. BASP1 is a transcriptional cosuppressor for the Wilms? tumor suppressor protein WT1. Mol Cell Biol 2004; 24: 537-549.
35. Boldogh IR, Pon LA. Interactions of mitochondria with the actin cytoskeleton. Biochim Biophys Acta 2006; 1763: 450-462.
36. Wiederkehr A, Staple J, Caroni P. The motility-associated proteins GAP-43, MARCKS, and CAP-23 share unique targeting and surface activityinducing properties. Exp Cell Res 1997; 236: 103-116.
37. Geraldes P, Hiraoka-Yamamoto J, Matsumoto M et al. Activation of PKCdelta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med 2009; 15: 1298-1306.
38. Lindenmeyer MT, Kretzler M, Boucherot A et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 2007; 18: 1765-1776.
39. Kelly DJ, Cox AJ, Tolcos M et al. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats. Kidney Int 2002; 61: 31-39.
40. Brosius III FC, Kaufman RJ. Is the ER stressed out in diabetic kidney disease? J Am Soc Nephrol 2008; 19: 2040-2042.
41. Justo P, Lorz C, Sanz A et al. Intracellular mechanisms of cyclosporin Ainduced tubular cell apoptosis. J Am Soc Nephrol 2003; 14: 3072-3080.
42. Nakagawa T, Zhu H, Morishima N et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloidbeta. Nature 2000; 403: 98-103.
43. Zinszner H, Kuroda M, Wang X et al. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 1998; 12: 982-995.
44. Kimura K, Jin H, Ogawa M et al. Dysfunction of the ER chaperone BiP accelerates the renal tubular injury. Biochem Biophys Res Commun 2008; 366: 1048-1053.
45. Cybulsky AV. Endoplasmic reticulum stressin proteinuric kidney disease. Kidney Int 2010; 77: 187-193.
46. Liu G, Sun Y, Li Z et al. Apoptosis induced by endoplasmic reticulum stress involved in diabetic kidney disease. Biochem Biophys Res Commun 2008; 370: 651-656.
47. Brezniceanu ML, Lau CJ, Godin N et al. Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy. J Am Soc Nephrol 2010; 21: 943-954.
48. Mishra R, Emancipator SN, Kern T et al. High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. Kidney Int 2005; 67: 82-93.
49. Saleh M, Vaillancourt JP, Graham RK et al. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 2004; 429: 75-79.
50. Rodwell GE, Sonu R, Zahn JM et al. A transcriptional profile of aging in the human kidney. PLoS Biol 2004; 2: e427.